Recent Finacing
Recent Raise
BioFactura develops biosimilar biologics and specializes in creating stable manufacturing cell lines and scalable R&D/manufacturing processes for therapeutic protein drugs, particularly monoclonal antibodies.
Focus Areas
Total Raised
Funding round